Form 8-K · Current report
Marsh McLennan 8-K, filed Jul 21, 2026
- Filed
- CIK
- 0000062709
- Accession no.
- 0000062709-26-000193
Summary
Marsh (NYSE: MRSH) reported second-quarter 2026 revenue of $7.4 billion, up 6% from a year earlier and 5% on an underlying basis, with adjusted EPS rising 9% to $2.96; CEO John Doyle attributed the results to demand across risk, people, strategy and investments. The board raised the quarterly dividend 10% to $0.990 per share, payable August 14, 2026, and the company repurchased about 4.5 million shares for $750 million in the quarter.
Key points
- Second-quarter GAAP operating income rose 4% to $1.9 billion and adjusted operating income rose 5% to $2.2 billion.
- Second-quarter GAAP EPS was $2.63; six-month GAAP EPS was $4.99 and adjusted EPS rose 8% to $6.25.
- Consulting revenue rose 10% to $2.6 billion, while Risk & Insurance Services revenue rose 4% to $4.8 billion and Guy Carpenter revenue fell 2% to $664 million.
- Through the first six months of 2026 the company repurchased 8.7 million shares for $1.5 billion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition On July 21, 2026, Marsh & McLennan Companies, Inc. issued a press release reporting financial results for the second quarter ended June 30, 2026, and announcing that a conference call to discuss such results will be held at 8:30 a.m. Eastern time on July 21, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. For purposes of Section 18 of the Securities Exchange Act of 1934, the press release is deemed furnished not filed. Item 9.01 Financial Statements and Exhibits (d) Exhibits 99.1 Press release issued by Marsh & McLennan Companies, Inc. on July 21, 2026. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.